Skip to main content

Advertisement

SpringerLink
Log in

The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: Comparison with diazepam

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Zolpidem is a short-acting, non-benzodiazepine hypnotic that acts as a full agonist at α1-containing GABAA receptors. Overall, zolpidem purportedly has fewer instances of abuse and dependence than traditionally used benzodiazepines. However, several studies have shown that zolpidem may be more similar to benzodiazepines in terms of behavioral tolerance and withdrawal symptoms.

Objectives

In the current study, we examined whether subchronic zolpidem or diazepam administration produced deficits in zolpidem’s locomotor-impairing effects, anxiety-like behaviors, and changes in GABAAR subunit messenger RNA (mRNA).

Methods

Mice were given subchronic injections of either zolpidem (10 mg/kg), diazepam (20 mg/kg), or vehicle twice daily for 7 days. On day 8, mice were given a challenge dose of zolpidem (2 mg/kg) or vehicle before open field testing. Another set of mice underwent the same injection regimen but were sacrificed on day 8 for qRT-PCR analysis.

Results

We found that subchronic zolpidem and diazepam administration produced deficits in the acute locomotor-impairing effects of zolpidem and increased anxiety-like behaviors 1 day after drug termination. In addition, we found that subchronic treatment of zolpidem and diazepam induced distinct but overlapping GABAAR subunit mRNA changes in the cortex but few changes in the hippocampus, amygdala, or prefrontal cortex. Levels of mRNA measured in separate mice after a single injection of either zolpidem or diazepam revealed no mRNA changes.

Conclusions

In mice, subchronic treatment of zolpidem and diazepam can produce deficits in the locomotor-impairing effects of zolpidem, anxiety-like withdrawal symptoms, and subunit-specific mRNA changes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Acikmese B, Haznedar S, Hatipoglu I, Enginar N (2012) Evaluation of anxiolytic effect and withdrawal anxiety in chronic intermittent diazepam treatment in rats. Behav Pharmacol 23:215–219

    PubMed  Google Scholar 

  • Aitta-aho T, Vekovischeva OY, Neuvonen PJ, Korpi ER (2009) Reduced benzodiazepine tolerance, but increased flumazenil-precipitated withdrawal in AMPA-receptor GluR-A subunit-deficient mice. Pharmacol Biochem Behav 92:283–290

    CAS  PubMed  Google Scholar 

  • Ali NJ, Olsen RW (2001) Chronic benzodiazepine treatment of cells expressing recombinant GABAA receptors uncouples allosteric binding: studies on possible mechanisms. J Neurochem 79:1100–1108

    CAS  PubMed  Google Scholar 

  • Allison C, Pratt JA (2003) Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacol Ther 98:171–195

    CAS  PubMed  Google Scholar 

  • Allison C, Claase LA, Pratt JA (2002) Diazepam withdrawal-induced anxiety and place aversion in the rat: differential effects of two chronic diazepam treatment regimes. Behav Pharmacol 13:417–425

    CAS  PubMed  Google Scholar 

  • Allison C, Pratt JA, Ripley TL, Stephens DN (2005) Alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor autoradiography in mouse brain after single and repeated withdrawal from diazepam. Eur J Neurosci 21:1045–1056

    CAS  PubMed  Google Scholar 

  • Aragona M (2000) Abuse, dependence, and epileptic seizures after zolpidem withdrawal: review and case report. Clin Neuropharmacol 23:281–283

    CAS  PubMed  Google Scholar 

  • Araujo F, Tan S, Ruano D, Schoemaker H, Benavides J, Vitorica J (1996) Molecular and pharmacological characterization of native cortical γ-aminobutyric acidA receptors containing both α1 and α3 subunits. J Biol Chem 271:27902–27911

    CAS  PubMed  Google Scholar 

  • Arnot MI, Davies M, Martin IL, Bateson AN (2001) GABA(A) receptor gene expression in rat cortex: differential effects of two chronic diazepam treatment regimes. J Neurosci Res 64:617–625

    CAS  PubMed  Google Scholar 

  • Asan E, Yilmazer-Hanke DM, Eliava M, Hantsch M, Lesch K-P, Schmitt A (2005) The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the rat. Neuroscience 131:953–967

    CAS  PubMed  Google Scholar 

  • Atack JR, Hutson PH, Collinson N, Marshall G, Bentley G, Moyes C, Cook SM, Collins I, Wafford K, McKernan RM, Dawson GR (2005) Anxiogenic properties of an inverse agonist selective for α3 subunit-containing GABAA receptors. Br J Pharmacol 144:357–366

    CAS  PubMed Central  PubMed  Google Scholar 

  • Auta J, Giusti P, Guidotti A, Costa E (1994) Imidazenil, a partial positive allosteric modulator of GABAA receptors, exhibits low tolerance and dependence liabilities in the rat. J Pharmacol Exp Ther 270:1262–1269

    CAS  PubMed  Google Scholar 

  • Auta J, Impagnatiello F, Kadriu B, Guidotti A, Costa E (2008) Imidazenil: a low efficacy agonist at alpha1- but high efficacy at α5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem. Neuropharmacology 55:148–153

    CAS  PubMed Central  PubMed  Google Scholar 

  • Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup C, Bateson AN, Langer SZ (1998) International union of pharmacology. XV. Subtypes of γ-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50:291–314

    CAS  PubMed  Google Scholar 

  • Bateson AN (2002) Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal. Curr Pharm Des 8:5–21

    CAS  PubMed  Google Scholar 

  • Benavides J, Peny B, Dubois A, Perrault G, Morel E, Zivkovic B, Scatton B (1988) In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype. J Pharmacol Exp Ther 245:1033–1041

    CAS  PubMed  Google Scholar 

  • Benavides J, Peny B, Ruano D, Vitorica J, Scatton B (1993) Comparative autoradiographic distribution of central ω (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem. Brain Res 604:240–250

    CAS  PubMed  Google Scholar 

  • Benca RM (2005) Diagnosis and treatment of chronic insomnia: a review. Psychiatr Serv 56:332–343

    PubMed  Google Scholar 

  • Biggio G, Dazzi L, Biggio F, Mancuso L, Talani G, Busonero F, Mostallino MC, Sanna E, Follesa P (2003) Molecular mechanisms of tolerance to and withdrawal of GABAA receptor modulators. Eur Neuropsychopharmacol 13:411–423

    CAS  PubMed  Google Scholar 

  • Blanchard DC, Griebel G, Blanchard RJ (2001) Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci Biobehav Rev 25:205–218

    CAS  PubMed  Google Scholar 

  • Burt DR, Kamatchi GL (1991) GABAA receptor subtypes: from pharmacology to molecular biology. FASEB J 5:2916–2923

    CAS  PubMed  Google Scholar 

  • Clark JD, Gebhart GF, Gonder JC, Keeling ME, Kohn DF (1997) Special Report: the 1996 guide for the care and use of laboratory animals. The National Academies Press, Bethesda, MD

    Google Scholar 

  • Cohen C, Sanger DJ (1994) Tolerance, cross-tolerance and dependence measured by operant responding in rats treated with triazolam via osmotic pumps. Psychopharmacology (Berl) 115:86–94

    CAS  Google Scholar 

  • Crestani F, Löw K, Keist R, Mandelli M-J, Möhler H, Rudolph U (2001) Molecular targets for the myorelaxant action of diazepam. Mol Pharmacol 59:442–445

    CAS  PubMed  Google Scholar 

  • Cubala WJ, Landowski J (2007) Seizure following sudden zolpidem withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 31:539–540

    CAS  PubMed  Google Scholar 

  • Davis M (2000) The role of the amygdala in conditioned and unconditioned fear and anxiety. In: Aggleton JP (ed) The amygdala : A functional analysis. Oxford University Press, New York, pp 213–287

    Google Scholar 

  • Diaz-Garcia JM, Oliver-Botana J, Fos-Galve D (1992) Pharmacokinetics of diazepam in the rat: influence of a carbon tetrachloride-induced hepatic injury. J Pharm Sci 81:768–772

    CAS  PubMed  Google Scholar 

  • Divljaković J, Milić M, Namjoshi OA, Tiruveedhula VV, Timić T, Cook JM, Savić MM (2013) βCCT, an antagonist selective for α1GABAA receptors, reverses diazepam withdrawal-induced anxiety in rats. Brain Res Bull 91:1–7

    PubMed Central  PubMed  Google Scholar 

  • Drover DR (2004) Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone. Clin Pharmacokinet 43:227–238

    CAS  PubMed  Google Scholar 

  • Duncan GE, Breese GR, Criswell HE, McCown TJ, Herbert JS, Devaud LL, Morrow AL (1995) Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the alpha 1, beta 2 and gamma 2 subunits of GABAA receptors in rat brain. Neuroscience 64:1113–1128

    CAS  PubMed  Google Scholar 

  • Duncan GE, Knapp DJ, Breese GR, Crews FT, Little KY (1998) Species differences in regional patterns of 3H-8-OH-DPAT and 3H-zolpidem binding in the rat and human brain. Pharmacol Biochem Behav 60:439–448

    CAS  PubMed  Google Scholar 

  • Ebert B, Anderson NJ, Cremers TI, Rasmussen S, Vogel V, Fahey JM, Sánchez C (2008) Gaboxadol—a different hypnotic profile with no tolerance to sleep EEG and sedative effects after repeated daily dosing. Pharmacol Biochem Behav 90:113–122

    CAS  PubMed  Google Scholar 

  • Elliot EE, White JM (2000) Precipitated and spontaneous withdrawal following administration of lorazepam but not zolpidem. Pharmacol Biochem Behav 66:361–369

    CAS  PubMed  Google Scholar 

  • Fahey JM, Pritchard GA, Grassi JM, Pratt JS, Shader RI, Greenblatt DJ (1999) In situ hybridization histochemistry as a method to assess GABA(A) receptor subunit mRNA expression following chronic alprazolam administration. J Psychopharmacol 13:211–218

    CAS  PubMed  Google Scholar 

  • Fernandes C, File SE, Berry D (1996) Evidence against oppositional and pharmacokinetic mechanisms of tolerance to diazepam's sedative effects. Brain Res Bull 734:236–242

    CAS  Google Scholar 

  • Fernandes C, Arnot MI, Irvine EE, Bateson AN, Martin IL, File SE (1999) The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam. Psychopharmacology (Berl) 145:251–259

    CAS  Google Scholar 

  • File SE (1985) Tolerance to the behavioral actions of benzodiazepines. Neurosci Biobehav Rev 9:113–121

    CAS  PubMed  Google Scholar 

  • File SE (1990) The history of benzodiazepine dependence: a review of animal studies. Neurosci Biobehav Rev 14:135–146

    CAS  PubMed  Google Scholar 

  • Follesa P, Cagetti E, Mancuso L, Biggio F, Manca A, Maciocco E, Massa F, Desole MS, Carta M, Busonero F, Sanna E, Biggio G (2001) Increase in expression of the GABA(A) receptor alpha(4) subunit gene induced by withdrawal of, but not by long-term treatment with, benzodiazepine full or partial agonists. Brain Res Mol Brain Res 92:138–148

    CAS  PubMed  Google Scholar 

  • Friedman H, Abernethy DR, Greenblatt DJ, Shader RI (1986) The pharmacokinetics of diazepam and desmethyldiazepam in rat brain and plasma. Psychopharmacology (Berl) 88:267–270

    CAS  Google Scholar 

  • Galpern WR, Lumpkin M, Greenblatt DJ, Shader RI, Miller LG (1991) Chronic benzodiazepine administration. VII. Behavioral tolerance and withdrawal and receptor alterations associated with clonazepam administration. Psychopharmacology (Berl) 104:225–230

    CAS  Google Scholar 

  • Garrigou-Gadenne D, Burke JT, Durand A, Depoortere H, Thenot JP, Morselli PL (1989) Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat. J Pharmacol Exp Ther 248:1283–1288

    CAS  PubMed  Google Scholar 

  • Gericke CA, Ludolph AC (1994) Chronic abuse of zolpidem. JAMA 272:1721–1722

    CAS  PubMed  Google Scholar 

  • Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C (2001) An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25:386–401

    CAS  PubMed  Google Scholar 

  • Glisovic T, Bachorik JL, Yong J, Dreyfuss G (2008) RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett 582:1977–1986

    CAS  PubMed Central  PubMed  Google Scholar 

  • Gravielle MC, Faris R, Russek SJ, Farb DH (2005) GABA induces activity dependent delayed-onset uncoupling of GABA/benzodiazepine site interactions in neocortical neurons. J Biol Chem 280:20954–20960

    CAS  PubMed  Google Scholar 

  • Greenblatt DJ, Roth T (2012) Zolpidem for insomnia. Expert Opin Pharmacother 13:879–893

    CAS  PubMed  Google Scholar 

  • Griebel G, Perrault G, Letang V, Granger P, Avenet P, Schoemaker H, Sanger DJ (1999) New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes. Psychopharmacology (Berl) 146:205–213

    CAS  Google Scholar 

  • Griffiths RR, Weerts EM (1997) Benzodiazepine self-administration in humans and laboratory animals—implications for problems of long-term use and abuse. Psychopharmacology (Berl) 134:1–37

    CAS  Google Scholar 

  • Griffiths RR, Sannerud CA, Ator NA, Brady JV (1992) Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal. J Pharmacol Exp Ther 260:1199–1208

    CAS  PubMed  Google Scholar 

  • Hajak G, Muller WE, Wittchen HU, Pittrow D, Kirch W (2003) Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98:1371–1378

    CAS  PubMed  Google Scholar 

  • Heikkinen AE, Moykkynen TP, Korpi ER (2009) Long-lasting modulation of glutamatergic transmission in VTA dopamine neurons after a single dose of benzodiazepine agonists. Neuropsychopharmacology 34:290–298

    CAS  PubMed  Google Scholar 

  • Heldt SA, Ressler KJ (2007) Forebrain and midbrain distribution of major benzodiazepine-sensitive GABAA receptor subunits in the adult C57 mouse as assessed with in situ hybridization. Neuroscience 150:370–385

    CAS  PubMed Central  PubMed  Google Scholar 

  • Heninger C, Saito N, Tallman JF, Garrett KM, Vitek MP, Duman RS, Gallager DW (1990) Effects of continuous diazepam administration on GABAA subunit mRNA in rat brain. J Mol Neurosci 2:101–107

    CAS  PubMed  Google Scholar 

  • Hoffman JM, Shah ND, Vermeulen LC, Schumock GT, Grim P, Hunkler RJ, Hontz KM (2007) Projecting future drug expenditures–2007. Am J Health Syst Pharm 64:298–314

    PubMed  Google Scholar 

  • Holt RA, Bateson AN, Martin IL (1996) Chronic treatment with diazepam or abecarnil differently affects the expression of GABAA receptor subunit mRNAs in the rat cortex. Neuropharmacology 35:1457–1463

    CAS  PubMed  Google Scholar 

  • Holt RA, Bateson AN, Martin IL (1997) Chronic zolpidem treatment alters GABA(A) receptor mRNA levels in the rat cortex. Eur J Pharmacol 329:129–132

    CAS  PubMed  Google Scholar 

  • Huang MC, Lin HY, Chen CH (2007) Dependence on zolpidem. Psychiatry Clin Neurosci 61:207–208

    PubMed  Google Scholar 

  • Huopaniemi L, Keist R, Randolph A, Certa U, Rudolph U (2004) Diazepam-induced adaptive plasticity revealed by α1 GABAA receptor-specific expression profiling. J Neurochem 88:1059–1067

    CAS  PubMed  Google Scholar 

  • Impagnatiello F, Pesold C, Longone P, Caruncho H, Fritschy JM, Costa E, Guidotti A (1996) Modifications of gamma-aminobutyric acidA receptor subunit expression in rat neocortex during tolerance to diazepam. Mol Pharmacol 49:822–831

    CAS  PubMed  Google Scholar 

  • IMS-Health (2011) National (VONA) and total patient tracker (TPT). MS Health, Fairfield, CT

    Google Scholar 

  • Jacob TC, Michels G, Silayeva L, Haydon J, Succol F, Moss SJ (2012) Benzodiazepine treatment induces subtype-specific changes in GABAA receptor trafficking and decreases synaptic inhibition. Proc Natl Acad Sci USA 109:18595–18600

    CAS  PubMed Central  PubMed  Google Scholar 

  • Jardim MC, Nogueira RL, Graeff FG, Nunes-de-Souza RL (1999) Evaluation of the elevated T-maze as an animal model of anxiety in the mouse. Brain Res Bull 48:407–411

    CAS  PubMed  Google Scholar 

  • Kang I, Miller LG (1991) Decreased GABAA receptor subunit mRNA concentrations following chronic lorazepam administration. Br J Pharmacol 103:1285–1287

    CAS  PubMed Central  PubMed  Google Scholar 

  • King DA, Bouton ME, Musty RE (1987) Associative control of tolerance to the sedative effects of a short-acting benzodiazepine. Behav Neurosci 101:104–114

    CAS  PubMed  Google Scholar 

  • Kittler JT, Delmas P, Jovanovic JN, Brown DA, Smart TG, Moss SJ (2000) Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons. J Neurosci 20:7972–7977

    CAS  PubMed  Google Scholar 

  • Korpi ER, Mihalek RM, Sinkkonen ST, Hauer B, Hevers W, Homanics GE, Sieghart W, Luddens H (2002) Altered receptor subtypes in the forebrain of GABA(A) receptor delta subunit-deficient mice: recruitment of gamma 2 subunits. Neuroscience 109:733–743

    CAS  PubMed  Google Scholar 

  • Kripke DF (2007) Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry 7:42

    PubMed Central  PubMed  Google Scholar 

  • Lader M (2011) Benzodiazepines revisited—will we ever learn? Addiction 106:2086–2109

    PubMed  Google Scholar 

  • Lau CE, Sun L, Wang Q, Falk JL (2002) The effect of zolpidem on operant behavior and its relation to pharmacokinetics after intravenous and subcutaneous administration: concentration-effect relations. Behav Pharmacol 13:93–103

    CAS  PubMed  Google Scholar 

  • Liappas IA, Malitas PN, Dimopoulos NP, Gitsa OE, Liappas AI, Nikolaou CK, Christodoulou GN (2003) Zolpidem dependence case series: possible neurobiological mechanisms and clinical management. J Psychopharmacol 17:131–135

    CAS  PubMed  Google Scholar 

  • Longone P, Impagnatiello F, Guidotti A, Costa E (1996) Reversible modification of GABAA receptor subunit mRNA expression during tolerance to diazepam-induced cognition dysfunction. Neuropharmacology 35:1465–1473

    CAS  PubMed  Google Scholar 

  • Loscher W, Schwark WS (1985) Development of tolerance to the anticonvulsant effect of diazepam in amygdala-kindled rats. Exp Neurol 90:373–384

    CAS  PubMed  Google Scholar 

  • Low K, Crestani F, Keist R, Benke D, Brunig I, Benson JA, Fritschy JM, Rulicke T, Bluethmann H, Mohler H, Rudolph U (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131–134

    CAS  PubMed  Google Scholar 

  • Lukas SE, Griffiths RR (1984) Precipitated diazepam withdrawal in baboons: effects of dose and duration of diazepam exposure. Eur J Pharmacol 100:163–171

    CAS  PubMed  Google Scholar 

  • Marin RH, Pérez MF, Duero DG, Ramirez OA (1999) Preexposure to drug administration context blocks the development of tolerance to sedative effects of diazepam. Pharmacol Biochem Behav 64:473–477

    CAS  PubMed  Google Scholar 

  • Markowitz GJ, Kadam SD, Boothe DM, Irving ND, Comi AM (2010) The pharmacokinetics of commonly used antiepileptic drugs in immature CD1 mice. Neuroreport 21:452–456

    CAS  PubMed Central  PubMed  Google Scholar 

  • McKernan RM, Whiting PJ (1996) Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci 19:139–143

    CAS  PubMed  Google Scholar 

  • Mehta AK, Ticku MK (1999) Prevalence of the GABAA receptor assemblies containing alpha1-subunit in the rat cerebellum and cerebral cortex as determined by immunoprecipitation: lack of modulation by chronic ethanol administration. Brain Res Mol Brain Res 67:194–199

    CAS  PubMed  Google Scholar 

  • Metten P, Belknap JK, Crabbe JC (1998) Drug withdrawal convulsions and susceptibility to convulsants after short-term selective breeding for acute ethanol withdrawal. Behav Brain Res 95:113–122

    CAS  PubMed  Google Scholar 

  • Miller LG, Woolverton S, Greenblatt DJ, Lopez F, Roy RB, Shader RI (1989) Chronic benzodiazepine administration. IV. Rapid development of tolerance and receptor downregulation associated with alprazolam administration. Biochem Pharmacol 38:3773–3777

    CAS  PubMed  Google Scholar 

  • Murphy HM, Ihekoronze C, Wideman CH (2011) Zolpidem-induced changes in activity, metabolism, and anxiety in rats. Pharmacol Biochem Behav 98:81–86

    CAS  PubMed  Google Scholar 

  • Perrault G, Morel E, Sanger DJ, Zivkovic B (1990) Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. Eur J Pharmacol 187:487–494

    CAS  PubMed  Google Scholar 

  • Perrault G, Morel E, Sanger DJ, Zivkovic B (1992) Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem. J Pharmacol Exp Ther 263:298–303

    CAS  PubMed  Google Scholar 

  • Pesold C, Caruncho HJ, Impagnatiello F, Berg MJ, Fritschy JM, Guidotti A, Costa E (1997) Tolerance to diazepam and changes in GABAA receptor subunit expression in rat neocortical areas. Neuroscience 79:477–487

    CAS  PubMed  Google Scholar 

  • Petroski RE, Pomeroy JE, Das R, Bowman H, Yang W, Chen AP, Foster AC (2006) Indiplon is a high-affinity positive allosteric modulator with selectivity for α1 subunit-containing GABAA receptors. J Pharmacol Exp Ther 317:369–377

    CAS  PubMed  Google Scholar 

  • Petursson H (1994) The benzodiazepine withdrawal syndrome. Addiction 89:1455–1459

    CAS  PubMed  Google Scholar 

  • Pieri L, Schaffner R, Scherschlicht R, Polc P, Sepinwall J, Davidson A, Mohler H, Cumin R, Da Prada M, Burkard WP, Keller HH, Muller RK, Gerold M, Pieri M, Cook L, Haefely W (1981) Pharmacology of midazolam. Arzneimittelforschung 31:2180–2201

    CAS  PubMed  Google Scholar 

  • Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, Sperk G (2000) GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101:815–850

    CAS  PubMed  Google Scholar 

  • Pugh SL, Boone MS, Emmett-Oglesby MW (1992) Tolerance, cross-tolerance and withdrawal in rats made dependent on diazepam. J Pharmacol Exp Ther 262:751–758

    CAS  PubMed  Google Scholar 

  • Renger JJ, Dunn SL, Motzel SL, Johnson C, Koblan KS (2004) Sub-chronic administration of zolpidem affects modifications to rat sleep architecture. Brain Res 1010:45–54

    CAS  PubMed  Google Scholar 

  • Roehrs TA, Randall S, Harris E, Maan R, Roth T (2012) Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study. J Psychopharmacol 26:1088–1095

    PubMed Central  PubMed  Google Scholar 

  • Sanger DJ, Zivkovic B (1987) Investigation of the development of tolerance to the actions of zolpidem and midazolam. Neuropharmacology 26:1513–1518

    CAS  PubMed  Google Scholar 

  • Sanger DJ, Zivkovic B (1992) Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors. Neuropharmacology 31:693–700

    CAS  PubMed  Google Scholar 

  • Sanna E, Busonero F, Talani G, Carta M, Massa F, Peis M, Maciocco E, Biggio G (2002) Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABAA receptor subtypes. Eur J Pharmacol 451:103–110

    CAS  PubMed  Google Scholar 

  • Schmid L, Bottlaender M, Fuseau C, Fournier D, Brouillet E, Mazière M (1995) Zolpidem displays heterogeneity in its binding to the nonhuman primate benzodiazepine receptor in vivo. J Neurochem 65:1880–1886

    CAS  PubMed  Google Scholar 

  • Sethi PK, Khandelwal DC (2005) Zolpidem at supratherapeutic doses can cause drug abuse, dependence and withdrawal seizure. J Assoc Physicians India 53:139–140

    CAS  PubMed  Google Scholar 

  • Siegel S (1989) Pharmacological conditioning and drug effects. In: Goudie AJ, Emmett-Oglesby MW (eds) Psychoactive drugs: Tolerance and sensitization. Humana Press, Totowa, pp 115–180

    Google Scholar 

  • Smith PF, Darlington CL (1994) The behavioural effects of long-term use of benzodiazepine sedative and hypnotic drugs: what can be learned from animal studies? N Z J Psychol 23:48–63

    Google Scholar 

  • Smith R, Wright BT, Heldt SA (2011) Tolerance and withdrawal effects of zolpidem in mice given chronic zolpidem treatment Society for Neuroscience. Neuroscience Meeting Planner, Washington, DC

    Google Scholar 

  • Steppuhn KG, Turski L (1993) Diazepam dependence prevented by glutamate antagonists. Proc Natl Acad Sci USA 90:6889–6893

    CAS  PubMed Central  PubMed  Google Scholar 

  • Tietz EI, Huang X, Chen S, Ferencak Iii WF (1999) Temporal and regional regulation of α1, β2 and β3, but not α2, α4, α5, α6, β1 or γ2 GABAA receptor subunit messenger RNAs following one-week oral flurazepam administration. Neuroscience 91:327–341

    CAS  PubMed  Google Scholar 

  • Trenque T, Bustany P, Lamiable D, Legros S, Choisy H (1994) Pharmacokinetics and brain distribution of zolpidem in the rat after acute and chronic administration. J Pharm Pharmacol 46:611–613

    CAS  PubMed  Google Scholar 

  • Uusi-Oukari M, Korpi ER (2010) Regulation of GABA(A) receptor subunit expression by pharmacological agents. Pharmacol Rev 62:97–135

    CAS  PubMed  Google Scholar 

  • van Rijnsoever C, Tauber M, Choulli MK, Keist R, Rudolph U, Mohler H, Fritschy JM, Crestani F (2004) Requirement of α5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice. J Neurosci 24:6785–6790

    PubMed  Google Scholar 

  • Victorri-Vigneau C, Dailly E, Veyrac G, Jolliet P (2007) Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol 64:198–209

    PubMed Central  PubMed  Google Scholar 

  • Victorri-Vigneau C, Feuillet F, Wainstein L, Grall-Bronnec M, Pivette J, Chaslerie A, Sébille V, Jolliet P (2013) Pharmacoepidemiological characterisation of zolpidem and zopiclone usage. Eur J Clin Pharmacol 1–8

  • Vinkers CH, Olivier B (2012) Mechanisms underlying tolerance after long-term benzodiazepine use: a future for subtype-selective GABAA receptor modulators? Adv Pharmacol Sci. doi:10.1155/2012/416864

    PubMed Central  PubMed  Google Scholar 

  • Vinkers CH, van Oorschot R, Nielsen EO, Cook JM, Hansen HH, Groenink L, Olivier B, Mirza NR (2012) GABA(A) receptor alpha subunits differentially contribute to diazepam tolerance after chronic treatment. PLoS ONE 7:e43054. doi:10.1371/journal.pone.0043054 PONE-D-11-24285

    CAS  PubMed Central  PubMed  Google Scholar 

  • Vlainic J, Pericic D (2009) Effects of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam. Neuropharmacology 56:1124–1130

    CAS  PubMed  Google Scholar 

  • Vogel HG, Vogel WH (2002) Drug discovery and evaluation: pharmacological assays. Springer, New York

    Google Scholar 

  • VonVoigtlander PF, Lewis RA (1991) A rapid screening method for the assessment of benzodiazepine receptor-related physical dependence in mice. Evaluation of benzodiazepine-related agonists and partial agonists. J Pharmacol Methods 26:1–5

    CAS  PubMed  Google Scholar 

  • Voss J, Sanchez C, Michelsen S, Ebert B (2003) Rotarod studies in the rat of the GABAA receptor agonist gaboxadol: lack of ethanol potentiation and benzodiazepine cross-tolerance. Eur J Pharmacol 482:215–222

    CAS  PubMed  Google Scholar 

  • Walker MC, Tong X, Brown S, Shorvon SD, Patsalos PN (1998) Comparison of single- and repeated-dose pharmacokinetics of diazepam. Epilepsia 39:283–289

    CAS  PubMed  Google Scholar 

  • Ward BO, Stephens DN (1998) Sensitisation of withdrawal signs following repeated withdrawal from a benzodiazepine: differences between measures of anxiety and seizure sensitivity. Psychopharmacology 135:342–352

    CAS  PubMed  Google Scholar 

  • Weerts EM, Griffiths RR (1998) Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons. Behav Pharmacol 9:285–297

    CAS  PubMed  Google Scholar 

  • Weerts EM, Ator NA, Grech DM, Griffiths RR (1998) Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. J Pharmacol Exp Ther 285:41–53

    CAS  PubMed  Google Scholar 

  • Wisden W, Laurie DJ, Monyer H, Seeburg PH (1992) The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 12:1040–1062

    CAS  PubMed  Google Scholar 

  • Wu Y, Rosenberg HC, Chiu TH, Ramsey-Williams V (1994) Regional changes in [3H]zolpidem binding to brain benzodiazepine receptors in flurazepam tolerant rat: comparison with changes in [3H]flunitrazepam binding. J Pharmacol Exp Ther 268:675–682

    CAS  PubMed  Google Scholar 

  • Yanagita T, Takahashi S (1973) Dependence liability of several sedative-hypnotic agents evaluated in monkeys. J Pharmacol Exp Ther 185:307–316

    CAS  PubMed  Google Scholar 

  • Zamanillo D, Sprengel R, Hvalby Ø, Jensen V, Burnashev N, Rozov A, Kaiser KMM, Köster HJ, Borchardt T, Worley P, Lübke J, Frotscher M, Kelly PH, Sommer B, Andersen P, Seeburg PH, Sakmann B (1999) Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science 284:1805–1811

    CAS  PubMed  Google Scholar 

  • Zhao TJ, Chiu TH, Rosenberg HC (1994) Reduced expression of gamma-aminobutyric acid type A/benzodiazepine receptor gamma 2 and alpha 5 subunit mRNAs in brain regions of flurazepam-treated rats. Mol Pharmacol 45:657–663

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Support was provided by NIH (MH-086727), NARSAD, and a UTHSC base grant. Some of these results were reported at the meetings of the Society for Neuroscience (Smith et al. 2011). We would like to thank Jordan Marie Ross for her assistance with manuscript preparation and Regina Smith for assistance with data collection.

Author information

Authors and Affiliations

  1. The Department of Anatomy and Neurobiology, Neuroscience Institute, University of Tennessee Health Science Center, 855 Monroe Ave, Memphis, TN, 38163, USA

    Brittany T. Wright, Catherine F. Gluszek & Scott A. Heldt

Authors
  1. Brittany T. Wright
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Catherine F. Gluszek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Scott A. Heldt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Scott A. Heldt.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Online Resource 1

(PDF 302 kb)

Online Resource 2

mRNA expression levels in the amygdala (BLA) and prefrontal cortex (PFC) after sub-chronic treatment (VEH, DZP, or ZOLP). (PDF 301 kb)

Online Resource 3

mRNA expression levels in the cortex, hippocampus, amygdala (BLA) and prefrontal cortex (PFC) after acute (1-day) administration (VEH, DZP, or ZOLP). (PDF 254 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wright, B.T., Gluszek, C.F. & Heldt, S.A. The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: Comparison with diazepam. Psychopharmacology 231, 2967–2979 (2014). https://doi.org/10.1007/s00213-014-3473-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-014-3473-x

Keywords

Search

Navigation